Page 110 - 南京医科大学自然版
P. 110
第44卷第7期
·994 · 南 京 医 科 大 学 学 报 2024年7月
表1 全球良恶性乳腺病及癌旁、正常乳腺组织的微生物组测序研究情况
Table 1 Global microbiome sequencing studies of benign and malignant breast disease and paraneoplastic and normal
breast tissue
16S rRNA
Time Area Sample type and sample size Sequencing method
amplification region
2023 Morocco [11] BCT(n=47),NAT( n=47) Illumina MiSeq System V3-V4
[12]
2023 China BCT(n=18),NAT(n=18),BDT(n=8) Oxford Nanoporelong⁃read sequencing -
[13]
2022 USA NT(n=49),NAT(n=49),BCT(n=61) Illumina MiSeq sequencing V3-V4
[14]
2022 USA Normal adjacent tissues from BDT(n=12), Illumina MiSeq sequencing -
NAT(n=15)
NT(n=6),BCT(n=11),lymphoid metastases
[15]
2022 China Novaseq sequencing V4
tissues(n=4)
[16]
2022 Italy NAT(n=34),BCT(n=34) NGS V4-V6
2022 China [17] NAT(n=79),normal adjacent tissues from BDT Illumina Nova Seq 6000 platform V4
(n=15)
2021 Ireland [18] BCT(n=23),NAT(n=23),matched skin swab Illumina MiSeq sequencing V3-V4
samples(n=23)
[19]
2020 USA BCT(n=10),NT(n=36) Illumina MiSeq sequencing V1-V2
2020 USA [20] BCT from black non⁃Hispanic(n=10),matched Illumina MiSeq sequencing V3-V4
NAT from black non ⁃ Hispanic(n=10), BCT
from white non⁃Hispanic(n=23),matched NAT
from white non⁃Hispanic(n=23)
2020 Israel [21] NT(n=54),BDT(n=29),NAT(n=173),BCT ⁃ 5 short regions
(n=355)
[22]
2020 USA BCT underwent neoadjuvant chemotherapy(n= Illumina MiSeq sequencing V4
4),BCT with no prior therapy at time of surgery
(n=18)
2019 USA [23] BCT(n=64),NAT(n=11),NT(n=8) Illumina MiSeq sequencing V4
[24]
2018 Italy BCT(n=19),NAT(n=19) Illumina MiSeq Reagent Kit v3 V2、V3、V4、
V6 、V7、V8、V9
[25]
2018 China BDT(n=22),BCT(n=72) Illumina HiSeq sequencing V1-V2
2018 USA [26] ER positive BCT(n=50),HER2 positive BCT PathoChip Array -
(n=34),triple positive BCT(n=24),triple
negative BCT(n=40),NT(n=20)
[27]
2017 USA BCT(n=57),NAT(n=57),NT(n=21) Illumina Miseq sequencing V3-V4
2017 USA [28] BCT(n=668),NAT(n=72) Illuminasequencing V3-V5
2016 Canada [29] NAT(n=45),normal adjacent tissues from BDT Illumina MiSeq sequencing V6
(n=13),NT(n=23)
[30]
2016 USA NAT(n=15), normal adjacent tissues from Illumina MiSeq sequencing V3-V5
BDT(n=13)
2014 Canada [31] NAT(n=27), normal adjacent tissues from Ion Torrent platform V6
BDT(n=11),NT(n=5)
Ireland NAT(n=33),NT(n=5)
[32]
2014 USA BCT(n=20),NAT(n=20) Illumina MiSeq sequencing V4
Abbreviation:BCT,breast cancer tissue;BDT,benign disease tissue;NAT,normal adjacent tissue;NT,normal breast tissues.